← Back to Screener
Synergy CHC Corp. Common Stock (SNYR)
Price$0.51
Favorite Metrics
Price vs S&P 500 (26W)-81.26%
Price vs S&P 500 (4W)-64.48%
Market Capitalization$6.22M
P/E Ratio (Annual)3.41x
All Metrics
Book Value / Share (Quarterly)$0.07
P/TBV (Annual)15.86x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)-8.93%
Cash Flow / Share (Quarterly)$-0.23
Price vs S&P 500 (YTD)-73.08%
Gross Margin (TTM)66.83%
Net Profit Margin (TTM)-40.62%
EPS (TTM)$-1.03
10-Day Avg Trading Volume7.40M
EPS Excl Extra (TTM)$-1.03
Revenue Growth (5Y)-2.12%
EPS (Annual)$-1.27
ROI (Annual)-53.28%
Gross Margin (Annual)66.83%
Net Profit Margin (5Y Avg)-9.51%
Cash / Share (Quarterly)$0.23
P/E Basic Excl Extra (TTM)2.81x
Revenue Growth QoQ (YoY)-40.95%
EPS Growth (5Y)118.44%
P/E Normalized (Annual)3.41x
ROA (Last FY)-121.42%
Revenue Growth TTM (YoY)74.63%
EBITD / Share (TTM)$-0.63
ROE (5Y Avg)-100.02%
Operating Margin (TTM)-20.75%
Cash Flow / Share (Annual)$-0.23
P/B Ratio1.05x
P/B Ratio (Quarterly)2.88x
Net Income / Employee (Annual)$-1
EV / Revenue (TTM)1.00x
Net Interest Coverage (TTM)-1.06x
ROA (TTM)-74.53%
EPS Growth QoQ (YoY)-88.04%
EV / EBITDA (TTM)3.47x
EPS Incl Extra (Annual)$-1.27
Current Ratio (Annual)1.22x
Quick Ratio (Quarterly)0.73x
3-Month Avg Trading Volume0.85M
52-Week Price Return-69.28%
EV / Free Cash Flow (Annual)5.35x
P/E Incl Extra (TTM)2.81x
Revenue / Employee (TTM)$1
Tangible BV / Share (Quarterly)$0.04
P/S Ratio (Annual)0.20x
Asset Turnover (Annual)2.99x
52-Week High$4.08
Operating Margin (5Y Avg)0.32%
EPS Excl Extra (Annual)$-1.27
26-Week Price Return-77.28%
Quick Ratio (Annual)0.73x
13-Week Price Return-69.62%
Total Debt / Equity (Annual)1.91x
Current Ratio (Quarterly)1.22x
Enterprise Value$30.408
Revenue / Share Growth (5Y)-6.95%
Asset Turnover (TTM)1.83x
Revenue / Employee (Annual)$1
Inventory Turnover (Annual)3.70x
Pretax Margin (Annual)-40.24%
Cash / Share (Annual)$0.23
3-Month Return Std Dev86.34%
Gross Margin (5Y Avg)68.46%
Net Income / Employee (TTM)$-1
EBITDA CAGR (5Y)12.82%
EBITDA Interim CAGR (5Y)-4.00%
ROE (Last FY)-155.15%
Net Interest Coverage (Annual)-1.06x
EPS Basic Excl Extra (Annual)$-1.27
P/FCF (TTM)9.96x
Receivables Turnover (TTM)4.71x
EV / Free Cash Flow (TTM)3.37x
Total Debt / Equity (Quarterly)1.04x
EPS Incl Extra (TTM)$-1.03
Receivables Turnover (Annual)4.71x
ROI (TTM)-31.03%
P/S Ratio (TTM)0.20x
Pretax Margin (5Y Avg)-9.18%
Revenue / Share (Annual)$3.12
Tangible BV / Share (Annual)$0.13
Forward P/E3.90x
Price vs S&P 500 (52W)-99.11%
P/E Ratio (TTM)2.81x
EPS Growth TTM (YoY)-39.32%
Year-to-Date Return-70.44%
5-Day Price Return-10.44%
EPS Normalized (Annual)$-1.27
ROA (5Y Avg)-44.56%
Net Profit Margin (Annual)-40.62%
Month-to-Date Return-57.37%
Cash Flow / Share (TTM)$0.02
EBITD / Share (Annual)$-0.63
Operating Margin (Annual)-20.75%
LT Debt / Equity (Annual)1.42x
ROI (5Y Avg)-61.34%
P/E Excl Extra (TTM)2.81x
LT Debt / Equity (Quarterly)0.04x
EPS Basic Excl Extra (TTM)$-1.03
P/TBV (Quarterly)4.58x
P/B Ratio (Annual)3.85x
Inventory Turnover (TTM)3.70x
Pretax Margin (TTM)-40.24%
Book Value / Share (Annual)$0.53
Price vs S&P 500 (13W)-70.31%
Net Margin Growth (5Y)34.23%
Beta-5.03x
P/FCF (Annual)14.74x
Revenue / Share (TTM)$2.69
ROE (TTM)-71.59%
52-Week Low$0.53
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
4.14
4.14
4.13
4.13
Industry Peers — Pharmaceutical Preparations(15)
| Symbol | P/S Ratio (TTM) | Revenue Growth TTM (YoY) | Gross Margin (TTM) | EPS Growth (5Y) | Price |
|---|---|---|---|---|---|
SNYRSynergy CHC Corp. Common Stock | 0.20x | 74.63% | 66.83% | 118.44% | $0.51 |
CRONCronos Group Inc. Common Share | 7.06x | 24.63% | 42.81% | -49.98% | $2.68 |
TLRYTilray Brands, Inc. Common Stock | 0.92x | 3.82% | 27.68% | — | $6.79 |
CGCCanopy Growth Corporation Common Shares | 2.42x | 0.59% | 26.56% | — | $1.15 |
NAGENiagen Bioscience, Inc. Common Stock | 2.93x | 29.95% | 64.28% | — | $4.73 |
USNAUSANA Health Sciences Inc | 0.38x | 5.88% | 78.29% | -37.04% | $19.06 |
SNDLSundial Growers Inc. Common Shares | 0.58x | 2.82% | 27.33% | — | $1.51 |
MDWDMediWound Ltd. | 13.10x | -16.14% | 19.19% | — | $17.10 |
ACBAurora Cannabis Inc. Common Shares | 0.78x | 16.54% | 1.35% | — | $3.61 |
FTLFFitLife Brands, Inc. Common Stock | 1.34x | 1.34% | 37.58% | -20.04% | $9.25 |
BTMDBiote Corp. Class A Common Stock | 0.41x | -2.52% | 71.46% | -26.84% | $2.10 |
About
Synergy CHC Corp markets and distributes branded consumer health and wellness products including FOCUSfactor, Flat Tummy Tea, Hand MD, and Neuragen across multiple distribution channels. The company focuses on health-conscious consumers seeking nutrition, weight management, cognitive health, skincare, and wellness solutions. Flat Tummy operates as a dedicated lifestyle brand targeting women's nutrition and weight management needs.